KR840009091A - N-산화 피리딜 카르복실산 에스테르의 제조방법 - Google Patents

N-산화 피리딜 카르복실산 에스테르의 제조방법 Download PDF

Info

Publication number
KR840009091A
KR840009091A KR1019840002323A KR840002323A KR840009091A KR 840009091 A KR840009091 A KR 840009091A KR 1019840002323 A KR1019840002323 A KR 1019840002323A KR 840002323 A KR840002323 A KR 840002323A KR 840009091 A KR840009091 A KR 840009091A
Authority
KR
South Korea
Prior art keywords
oxidized
product
compound
carboxylic acid
ester
Prior art date
Application number
KR1019840002323A
Other languages
English (en)
Other versions
KR860001907B1 (ko
Inventor
쉐름(외3) 아르투르
Original Assignee
요트. 헤크만 : 엘. 하. 보니커
메르즈+콤파니 게엠베하 운트 콤파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 요트. 헤크만 : 엘. 하. 보니커, 메르즈+콤파니 게엠베하 운트 콤파니 filed Critical 요트. 헤크만 : 엘. 하. 보니커
Publication of KR840009091A publication Critical patent/KR840009091A/ko
Application granted granted Critical
Publication of KR860001907B1 publication Critical patent/KR860001907B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음

Description

N-산화 피리딜 카르복실산 에스테르의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (8)

  1. 다음 일반식을 갖는 N-산화 피리딜 카르복실산 에스테르의 제조방법에 있어서, 질소가 산화되지 않은 다음 일반식의 피리딜 카르복실산 에스테르를 과산화산이나 빙초산/과산화수소와 반응시킴으로써 N-산화시켜 필요한 N-산화화합물을 제조함을 특징으로 하는 N-산화 피리딜 카르복실산 에스테르의 제조방법.
    이 식에서 R은인데
    R에서, X는 수소원자, 직쇄상이나 측쇄상 C1-C5-알칼, C5-C12-시클로알킬, 1-아다만틸이나 시클로헥실아세틸이고, Y는 수소원자, 직쇄상이나 측쇄상 C1-C5-알킬,2-에틸벤조 푸라노일-3이나 C5-C12-시클로알킬 또는 2-〔(4-클로로 페녹시)-2메틸프로판오일옥시〕에틸이다.
  2. 제1항에 있어서, 출발 화합물이 2-시클헥실페닐니코 티네이트이며 생성물이 2-시클로헥실페닐니고 티네이트의 N-산화물임을 특징으로 하는 N-산화 피리딜 카르복실산 에스테르의 제조방법.
  3. 제1항에 있어서, 출발 화합물이 4-시클헥실페닐니코 티네이트이며 생성물이 4-시클로헥실페닐니고 티네이트의 N-솬화물임을 특징으로 하는 N-산화 피리딜 카르복실산 에스테르의 제조방법.
  4. 제1항에 있어서, 출발 화합물이 시클헥실페닐니코 티네이트인데 시클로헥실페닐니코티네이트에서 저급 알킬치환분 역시 페닐 고리상에 존재하며 생성물이 의의 N-산화물임을 특징으로 하는 N-산화 피리딜 카르복실, 에스테르의 제조방법.
  5. 제1항에 있어서, 출발 화합물이 2-t-부틸-4시클헥실페닐니코티네이트이며 생성물이 2-t-부틸-4-시클로헥실페닐니코티네이트이 N-산화물임을 특징으로 하는 N-산화 피리딜 카르복실산, 에스테르의 제조방법.
  6. 제1항에 있어서, 출발 화합물이 4-(2-에틸-3-옥소-베조푸란) 페닐니코티네이트이며 생성물이 4-(2-에틸-3-옥소-벤조푸란) 페닐니코티네이트의 N-산화물임을 특징으로 하는 N-산화 피리딜 카르복실, 에스테르의 제조방법.
  7. 제1항에있어서, 출발화합물이 1-〔2-(4-클로로 페녹시)-2메틸프로판오시〕-2-(니코틴오일옥시) 에탄이며 생성물이 1-〔2-(4-클로로 페녹시)-2-메틸프로판오시〕-2-(니코틴오일옥시) 에탄의 N-산화물임을 특징으로 하는 N-산화 피리딜 카르복실, 에스테르의 제조방법.
  8. 제1항에 있어서, 반응을 비 반응성 유기용매 존재하에서 약 -10°에서 60℃ 사이의 온도로 실시하되 과산화산이나 과산화수소를 과량으로 사용하여서 실시함을 특징으로 하는 N-산화 피리딜 카르복실, 에스테르의 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840002323A 1983-05-02 1984-04-30 N-산화 피리딜 카르복실산 에스테르의 제조방법 KR860001907B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19833315877 DE3315877A1 (de) 1983-05-02 1983-05-02 N-oxide von pyridyl-carbonsaeureestern, ein verfahren zu ihrer herstellung und pharmazeutische mittel, die diese verbindungen enthalten
DE3315877.0 1983-05-02
DEP3315877.0 1983-05-02

Publications (2)

Publication Number Publication Date
KR840009091A true KR840009091A (ko) 1984-12-24
KR860001907B1 KR860001907B1 (ko) 1986-10-24

Family

ID=6197884

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840002323A KR860001907B1 (ko) 1983-05-02 1984-04-30 N-산화 피리딜 카르복실산 에스테르의 제조방법

Country Status (24)

Country Link
US (1) US4758581A (ko)
JP (1) JPS59206357A (ko)
KR (1) KR860001907B1 (ko)
AU (1) AU564780B2 (ko)
BE (1) BE899558A (ko)
CA (1) CA1247092A (ko)
CH (1) CH660005A5 (ko)
CS (1) CS241082B2 (ko)
DE (1) DE3315877A1 (ko)
DK (1) DK159105C (ko)
ES (1) ES532079A0 (ko)
FI (1) FI80444C (ko)
FR (1) FR2545486B1 (ko)
GB (1) GB2139621B (ko)
GR (1) GR79862B (ko)
HU (1) HU191681B (ko)
IE (1) IE57393B1 (ko)
IL (1) IL71734A (ko)
IT (1) IT1206144B (ko)
LU (1) LU85344A1 (ko)
NL (1) NL8401357A (ko)
SE (1) SE454986B (ko)
YU (1) YU45900B (ko)
ZA (1) ZA843278B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1256M (fr) * 1961-06-26 1962-04-16 M I P Soc Amilloise De Prod Ch Médicament hypocholésterolémiant a base de n-oxyde de l'acide nicotinique.
GB1213162A (en) * 1966-11-16 1970-11-18 Astra Ab Serum lipid lowering pyridine derivatives and their preparation
AT291853B (de) * 1967-03-22 1971-08-10 Buero Patent Ag Automatische, gleislose Förderanlage
US4321268A (en) * 1979-02-08 1982-03-23 Merz & Co. Certain substituted phenyl esters of nicotinic acid, compositions and methods of using same
DE3009099A1 (de) * 1980-03-10 1981-09-17 Merz + Co GmbH & Co, 6000 Frankfurt Neue phenylester der nikotinsaeure und verfahren zu ihrer herstellung
GB2193359B (en) * 1986-07-31 1990-07-11 Multitone Electronics Plc Area communications systems
US4797656A (en) * 1987-01-28 1989-01-10 Keppler Charles N Appliance paging system
US5012749A (en) * 1988-12-27 1991-05-07 The Allen Group Inc. Radio controlled material handling apparatus
US4962377A (en) * 1989-02-09 1990-10-09 Motorola, Inc. Paging by text matching

Also Published As

Publication number Publication date
IE841074L (en) 1984-11-02
HUT34162A (en) 1985-02-28
FI80444B (fi) 1990-02-28
KR860001907B1 (ko) 1986-10-24
IT8420763A0 (it) 1984-05-02
IL71734A0 (en) 1984-09-30
YU74384A (en) 1986-10-31
CS325284A2 (en) 1985-06-13
GB2139621B (en) 1986-10-29
JPS59206357A (ja) 1984-11-22
AU564780B2 (en) 1987-08-27
SE8402297D0 (sv) 1984-04-26
ES8503660A1 (es) 1985-03-16
CS241082B2 (en) 1986-03-13
IT1206144B (it) 1989-04-14
SE8402297L (sv) 1984-11-03
DK216484A (da) 1984-11-03
FI80444C (fi) 1990-06-11
GR79862B (ko) 1984-10-31
DE3315877A1 (de) 1984-11-08
DK159105C (da) 1991-02-11
IE57393B1 (en) 1992-08-26
FI841736A0 (fi) 1984-05-02
ES532079A0 (es) 1985-03-16
LU85344A1 (fr) 1986-01-29
YU45900B (sh) 1992-09-07
GB8411081D0 (en) 1984-06-06
AU2760484A (en) 1984-11-08
NL8401357A (nl) 1984-12-03
CA1247092A (en) 1988-12-20
US4758581A (en) 1988-07-19
FR2545486A1 (fr) 1984-11-09
IL71734A (en) 1988-02-29
FI841736A (fi) 1984-11-03
DE3315877C2 (ko) 1989-11-30
ZA843278B (en) 1985-12-24
DK216484D0 (da) 1984-05-01
DK159105B (da) 1990-09-03
BE899558A (fr) 1984-11-05
GB2139621A (en) 1984-11-14
FR2545486B1 (fr) 1986-12-26
JPS6127389B2 (ko) 1986-06-25
CH660005A5 (de) 1987-03-13
SE454986B (sv) 1988-06-13
HU191681B (en) 1987-03-30

Similar Documents

Publication Publication Date Title
SU435612A1 (ru) Способ получения несимметричных эфир08 1,4-дигидропиридиндикарбоновых кислот
SU475771A3 (ru) Способ получени несимметричных 1,4-дигидропиридинов
KR840003614A (ko) 항염 작용을 갖는 피롤아세트 아미드의 제조방법
KR840009091A (ko) N-산화 피리딜 카르복실산 에스테르의 제조방법
KR890017231A (ko) 질소함유 퍼옥시카복실산 모노퍼설페이트
KR850003716A (ko) 치환 및 미치환된 2-카바모일니코틴산과 3-퀴놀린카르복실산의 제조방법
KR840007419A (ko) 1H,3H-피롤로[1,2-c]티아졸유도체의제조방법
KR940018368A (ko) 알킬 2-알킬-4-플루오로메틸티아졸카르복실레이트의 제조방법
US3048624A (en) Stabilization of peracids
GB1368309A (en) Process for producing a pyridine carboxylic acid
KR890000490A (ko) 복소다환식 방향족 화합물
JP2758408B2 (ja) 芳香族複素環式ペルオキシカルボン酸
GB997378A (en) Isothiazole derivatives
KR870004025A (ko) 헤테로시클로카보닐-및 아세틸-티아졸론의 제조방법
KR910004567A (ko) 피리딘 카르복시산 유도체의 제조방법
KR830009097A (ko) 이미다조/1,2-a/퀴놀린 유도체의 제조방법
KR880007416A (ko) 1,1,2,2-테트라히드로퍼플루오로알칸올 및 그 에스테르의 합성
KR940005574A (ko) 2,5-이치환된 피리딘의 제조방법
KR890001990A (ko) 헤테로고리형 퍼옥시카복실산
EP1067107A4 (en) PROCESS FOR PRODUCING CETOISOPHORONE DERIVATIVES AND INSTALLATION THEREFOR
IL97582A (en) Process for the preparation of pyridine carbudioates converted to fluoromethyl
KR860004004A (ko) 4-아실옥시-3-옥소- 부티르산 에스테르의 제조방법
KR870003987A (ko) 피리딜 알킬아민의 알킬카르복사미드 및 그 제조방법
GB992357A (en) 2,5-di[1,3,4-oxidazol-2-yl]-thiophene compounds
GB950897A (en) New piperidine derivatives and processes for their manufacture

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19931023

Year of fee payment: 8

LAPS Lapse due to unpaid annual fee